*Number of people taking Evrysdi as of February 2022. Evrysdi approved in August 2020.
†Evrysdi clinical trials did not include people aged 65 and older to determine whether they respond differently from those who are younger.
Evrysdi: Life in action
Meet some of the many people who have chosen Evrysdi.
Información de prescripción de Evrysdi® (risdiplam). Genentech, Inc.
Información de prescripción de Evrysdi® (risdiplam). Genentech, Inc.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.